Evidence on Changes In Aid Allocation Criteria

Australian and New Zealand Journal of Psychiatry, 2011

2020

Policy announcements and welfare Stoltenberg, C.A.; Lepetyuk, V. Link to publication General rights It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulations If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. July, 2009 Abstract In the presence of idiosyncratic risk, the public revelation of information a...

The user has requested enhancement of the downloaded file. All in-text references underlined in blue are linked to publications on ResearchGate, letting you access and read them immediately.

1997

ED435200 - Content Analysis of Funded Enhancement Project Applications--Fiscal Year 1995.

2003

Highlights supplement family and student payments over the decade from 2002-03 to 2012-13, making higher education financially accessible. Increases in total funds are important indicators of the resources being devoted to student assistance. But these figures may create an overly optimistic view of the benefits available to individual students because they do not account for increases in the number of students enrolled in postsecondary education.

Prevention Research Center For the Promotion of Human Development, 2005

2002

2017

This paper explains the problems associated with using the funding information on the Web of Science (WoS) to determine how research has been funded. Funding sources have been added to the WoS as searchable fields since late 2008. However a funding source can have several different names and can appear with different conventions for abbreviation, punctuation and format. We needed to have one name for each source and it was convenient for names to have the same format. We therefore use a coding system, which is described in detail. It identifies most individual funders, and gives their country and sector (public, private-non-profit, commercial or international). Some of the commercial funders listed are false positives as they have paid the author(s) for unrelated work. In addition, acknowledgements implicit from the addresses also needed to be coded for public, charity and commercial laboratories. These two sets of codes were then combined to permit a detailed analysis of funding fo...

The IDS Bulletin, 2009

A vital part of the renewed hope for a vaccine against the human immunodeficiency virus (HIV-1) is based on recent studies that have highlighted major sites of HIV-1 vulnerability that could be effectively targeted by a preventive vaccine. One of these potential vulnerabilities includes the dense cluster of carbohydrates surrounding HIV-1's envelope glycoproteins gp120 and gp41, typically referred to as the ''glycan shield.'' Recent data from several laboratories have shown that glycans on the HIV-1 envelope form key epitopes for broadly neutralizing antibodies (bNAb). Moreover, HIV-1 envelope glycans play an important role in viral transmission, antigenicity, and immu-nogenicity. The recent availability of novel tools and technologies has now allowed investigators to leverage gly-comic structure–function relationships in the design of candidate HIV-1 vaccines. Additionally, glycans modulate the immune response, playing an essential role in Fc receptor and complement activity. To promote cross-disciplinary collaboration and promote synergistic HIV-1-glycomics research, the National Institutes of Health (NIH) co-sponsored and convened a 1.5-day workshop entitled ''Functional Glycomics in HIV-1 Vaccine Design.'' The meeting focused on the role of glycan interactions with neutralizing antibodies, the influence of immunoglobulin G (IgG) Fc receptor glycosylation, newly available glycomics technologies, and how new information on the role of glycans could be applied in HIV-1 immunogen design strategies. This report summarizes the discussions of this workshop.